Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.
Illinois has enacted legislation banning AI chatbots for mental health therapy, joining Utah and Nevada in addressing concerns over AI’s impact on vulnerable populations.
Vietnamese adolescents face notable mental health challenges amid growing social media influence. This article explores the alarming statistics, the stigma surrounding mental health, and the emerging role of social media in providing suppor
Brief daily low-stakes exchanges—‘the clouds look like cotton candy’—build safety, activate reward circuits and sustain intimacy. Science explains why micro-connections matter and how clinicians and couples can use a 3‑minute practice to st
A multicenter double-blind RCT (n=160) found that 12 weeks of simvastatin (40 mg) added to escitalopram did not improve depressive symptoms versus placebo, although LDL, total cholesterol, and CRP were reduced.
A multicenter randomized trial in Japan found that a 12-week therapist-guided internet-based CBT program significantly reduced weekly bingeing and compensatory episodes in women with bulimia nervosa versus usual care (adjusted mean differen
A multisite RCT of a 12‑module smartphone CBT intervention for psychiatric inpatients did not change time to first suicide attempt overall, but sustained reductions in suicidal ideation and reduced recurrent attempts among patients with pri
Recent studies link irregular sleep to higher risks of type 2 diabetes, cardiometabolic diseases, all-cause mortality, and depression. Consistent sleep timing may offer crucial protection against these adverse outcomes.
Discover how embracing the ‘Let Them’ philosophy can enhance emotional resilience and improve interpersonal relationships.
Explore how stress impacts body weight, causing some to gain while others lose pounds due to hormonal and neural responses.
Explore the science behind shopping addiction, its impact on mental health, and practical solutions to manage compulsive buying behaviors.
Recent meta-analysis finds no significant benefit of standalone safety planning interventions in reducing suicidal ideation or behavior among adolescents, highlighting the need for more robust research.
A randomized clinical trial demonstrates that an Acceptance and Commitment Therapy-based parenting program reduces health care use, improves asthma control, and alleviates ADHD symptoms in children with both conditions.
A systematic review and meta-analysis reveals that paternal perinatal depression, anxiety, and stress are associated with adverse developmental outcomes in children, highlighting the need for targeted interventions for fathers during the pe
Explore how the gut, often called the ‘second brain,’ influences mood and mental health, and learn ways to nurture this connection for better emotional well-being.
New GRADE sub-study reveals that somatic symptoms of depression, not cognitive-affective symptoms, are chiefly associated with inflammation and insulin resistance in type 2 diabetes, highlighting a pathophysiological bridge for targeted int
Weekly LYN-005 demonstrated pharmacokinetic equivalence to daily risperidone, sustained therapeutic levels, and manageable safety in clinically stable patients, offering a novel option to address non-adherence in schizophrenia.
Semaglutide significantly reduced body weight without impacting psychotic symptoms or clozapine levels in people with schizophrenia and obesity on clozapine therapy.
Recent trials show no significant difference in smoking cessation rates between e-cigarettes and combination nicotine replacement therapy among patients discharged from inpatient substance use withdrawal services. Longitudinal analyses reve
Two randomized controlled trials evaluated immersive VR therapies targeting auditory verbal hallucinations and persecutory delusions in schizophrenia and psychosis, revealing modest benefits for hallucinations but no superior effect for cog
A UK multicentre, double-blind, placebo-controlled trial demonstrates that pramipexole augmentation at 2.5 mg reduces depressive symptoms in treatment-resistant unipolar depression at 12 weeks, with some adverse effects noted, supporting it
Open language-specific specialty feeds and department pages.